Amoxicillin capsules vs tablets is a comparison between two oral dosage forms containing the same single antibacterial ingredient. In U.S. FDA labeling, conventional amoxicillin capsules are available in 250 mg and 500 mg strengths, while conventional film-coated tablets are identified in 500 mg and 875 mg strengths. The 500 mg presentations therefore provide a direct example of two distinct pharmaceutical forms containing the same labeled amount of amoxicillin. They are not identical commercial products, however, and their FDA application records, inactive ingredients, physical characteristics, manufacturers and packaging can differ.
The distinction matters when reviewing a U.S. pharmacy listing or an existing prescription. A 500 mg capsule is generally a hard-shell dosage form containing amoxicillin, while a conventional 500 mg tablet is a compressed, film-coated product. DailyMed identifies separately labeled capsule and tablet presentations, including different product imprints and package configurations. Pharmacy pricing can depend on the dosage form, manufacturer, prescription quantity and payment method. A matching 500 mg strength does not independently authorize a pharmacy to change the prescribed dosage form or prove that a particular product is currently stocked.
This guide focuses on the practical differences between amoxicillin capsules and conventional tablets, especially the overlapping 500 mg strength and its implications for product identification, package comparisons and pharmacy quotations. It does not recommend a formulation for an individual patient or claim that one form is clinically superior. Detailed capsule and tablet product listings belong in the amoxicillin capsules guide and amoxicillin tablets guide. The generic amoxicillin overview explains the wider single-ingredient product category.
Conventional amoxicillin capsules and tablets contain the same active antibacterial ingredient, amoxicillin, commonly supplied as amoxicillin trihydrate. Both are oral prescription dosage forms used within their applicable FDA labeling. The primary difference in this comparison is the pharmaceutical form rather than the presence of another active ingredient.
A capsule contains its contents within a capsule shell. A conventional tablet is manufactured as a solid compressed dosage form and may have a film coating. These physical differences can affect the inactive ingredients, appearance, package labeling and dispensing product selected by a pharmacy.
The FDA does not treat capsule and tablet descriptions as interchangeable product-identification terms. Approval and labeling records specify the dosage form, route, strength and application. A 500 mg capsule and a 500 mg tablet should therefore be identified separately when reviewing FDA data or pharmacy inventory.
Both conventional forms must also be distinguished from chewable tablets and powder for oral suspension. Those are additional amoxicillin dosage forms with their own product characteristics. An oral capsule listing does not establish that the same manufacturer supplies a corresponding film-coated or chewable tablet.
This comparison concerns plain amoxicillin only. Augmentin and generic amoxicillin/clavulanate contain an additional active ingredient, clavulanate potassium. They belong to a different product category and should not be included in a capsule-versus-tablet comparison simply because they also contain amoxicillin.
The Augmentin vs amoxicillin comparison explains that ingredient distinction. This page keeps the focus on the two conventional oral forms of the single-ingredient medicine.
| Characteristic | Amoxicillin capsule | Amoxicillin conventional tablet |
|---|---|---|
| Active ingredient | Amoxicillin | Amoxicillin |
| FDA-labeled conventional strengths | 250 mg and 500 mg | 500 mg and 875 mg |
| Dosage form | Oral capsule | Oral film-coated tablet |
| Physical presentation | Capsule shell containing the formulation | Compressed tablet with a product-specific coating |
| Overlapping strength | 500 mg | 500 mg |
| Clavulanate | Not present | Not present |
| Prescription status | Prescription-only | Prescription-only |
| Pharmacy verification | Exact capsule product, strength and quantity | Exact tablet product, strength and quantity |
The 500 mg strength is the clearest basis for comparing conventional amoxicillin capsules with conventional tablets. FDA-labeled products exist in both forms, and each contains 500 mg of the same active ingredient. This permits a direct comparison of product identification and dispensing characteristics without involving different nominal drug strengths.
A DailyMed amoxicillin labeling record updated in July 2026 identifies 500 mg capsules and 500 mg film-coated tablets within its product descriptions. That record distinguishes the capsule and tablet using their dosage form and physical characteristics rather than treating them as a single presentation.
The shared active ingredient and strength do not mean that the two products have identical inactive ingredients. Capsule shells may contain gelatin, coloring agents and other excipients, while tablets may contain coating materials, disintegrants, binders and lubricants. The actual ingredient list depends on the approved product and labeler.
A 500 mg capsule and a 500 mg tablet may also differ in size, shape and imprint. These characteristics are useful for pharmacy identification but should not be generalized from one manufacturer's product to every other approved generic.
When a patient receives a different-looking amoxicillin product, the correct response is to confirm the medicine, strength and dosage form with the dispensing pharmacist. A change in appearance does not automatically mean that the active ingredient changed, but appearance alone cannot establish that the prescription was filled correctly.
The 500 mg overlap does not constitute advice to substitute capsules for tablets. Any proposed dosage-form change must be evaluated under the prescription, FDA approval relationships and applicable pharmacy requirements.
Conventional amoxicillin labeling also identifies 250 mg capsules and 875 mg tablets. These strengths demonstrate that the available capsule and tablet ranges are not identical. A 250 mg capsule listing is not a direct like-for-like strength comparison with an 875 mg tablet.
A pharmacy search may display several amoxicillin strengths together, making it important to identify both the dosage form and the number of milligrams in each unit. A result showing the correct active ingredient but the wrong strength is not an appropriate quotation for the existing prescription.
The presence of different strengths should not be used to construct an alternative regimen by combining or dividing products. The prescription's dosage form, strength, administration instructions and quantity remain controlling. Tablet scoring, where present, is a product-specific physical characteristic and should not be interpreted as general permission to alter a dose.
Chewable tablets and oral suspensions provide additional FDA-labeled ways in which amoxicillin is supplied. They should not be confused with conventional film-coated tablets or capsule products when comparing pharmacy prices or packaging.
The detailed product catalogs on amoxicillin capsules and amoxicillin tablets address individual presentations. The purpose of this section is to explain why the dosage form and strength must both match before a comparison is meaningful.
| Amoxicillin strength | Conventional capsule | Conventional film-coated tablet | Comparison implication |
|---|---|---|---|
| 250 mg | FDA-labeled presentation | Not among the 500 mg and 875 mg conventional tablet strengths in the referenced labeling | Do not assume that a conventional tablet counterpart is available from the same product line. |
| 500 mg | FDA-labeled presentation | FDA-labeled presentation | Direct strength overlap for capsule-versus-tablet product comparison. |
| 875 mg | Not among the 250 mg and 500 mg capsule strengths in the referenced labeling | FDA-labeled presentation | Do not treat a different capsule strength as the same prescription product. |
The FDA Orange Book identifies approved drug products by active ingredient, dosage form, route, strength, application and applicant. These fields make it possible to distinguish a 500 mg amoxicillin capsule from a 500 mg conventional tablet without relying on retail descriptions or promotional product names.
DailyMed supplies additional product-specific information, including the labeler's drug name, physical description, NDC and package records. Some published labels cover multiple amoxicillin dosage forms, while others apply only to a capsule or tablet product. The full label should be reviewed before assigning a particular NDC or imprint to a specific form.
One published DailyMed product family describes 500 mg amoxicillin capsules with the imprint AMOX 500 and GG 849. The same family describes 500 mg conventional tablets bearing GG-961 and 500. These are specific labeled examples, not universal identifying marks for all U.S. amoxicillin products.
Other generic manufacturers and repackagers may supply 500 mg capsules or tablets with different imprints, colors, NDCs and package configurations. A labeler's name is not always the name of the original ANDA holder or physical manufacturer.
FDA approval and an NDC listing support regulatory and package identification but do not guarantee commercial availability. Historical package records can remain relevant for understanding product presentations without confirming that a particular pharmacy currently stocks them.
Patients and caregivers should use the dispensing label and pharmacist to confirm an actual medicine. An online image or a remembered tablet appearance is not a substitute for verifying the prescribed product.
| Documented DailyMed example | 500 mg capsule | 500 mg tablet |
|---|---|---|
| Active ingredient | Amoxicillin | Amoxicillin |
| Dosage form | Capsule | Film-coated tablet |
| Example imprint | AMOX 500 / GG 849 | GG-961 / 500 |
| Example appearance | Yellow opaque capsule | White to yellowish tablet |
| Source scope | Specific published product labeling | Specific published product labeling |
| Current pharmacy availability | Not established by the label | Not established by the label |
Although conventional amoxicillin capsules and tablets contain the same antibacterial ingredient, their inactive ingredients can differ. Capsule products may use gelatin shells, coloring agents and substances that support powder filling and stability. Film-coated tablets may contain binders, disintegrants and coating materials.
For example, the DailyMed product family describing AMOX 500 / GG 849 capsules lists gelatin and coloring-related capsule-shell components. Its tablet description includes different excipients associated with the compressed and coated dosage form. Those lists establish product-specific differences rather than a rule applying to every amoxicillin capsule or tablet.
An inactive ingredient may matter to patients with a documented allergy, intolerance or other product-specific concern. However, a general assumption that capsules contain fewer ingredients or that tablets are always better tolerated is not supported by the dosage-form name alone.
The correct source for an excipient comparison is the actual manufacturer's or labeler's current product labeling. Two 500 mg capsules from different companies may also have different inactive ingredients, so capsule-versus-tablet comparisons should not rely on a single generic ingredient list.
Swallowing characteristics may differ because of the capsule shell, tablet dimensions or surface coating. A person who has difficulty swallowing the prescribed form should ask a pharmacist or clinician about appropriate options rather than opening capsules, crushing tablets or changing dosage forms independently.
These distinctions concern product identification and handling. They do not establish that one conventional form is inherently more effective or clinically preferable to the other.
Amoxicillin 500 mg capsules and tablets can appear in different manufacturer or repackager package sizes. An FDA-labeled product may be supplied to pharmacies in a stock bottle containing more units than an individual prescription requires. The number of units in the original package should not be confused with the amount prescribed for a specific patient.
DailyMed provides identifiable examples. A published amoxicillin capsule labeling record includes 500 mg capsules in 20-, 60-, 100- and 500-capsule bottles. A separate historical AMOXIL product record lists 500 mg tablets in bottles of 20, 100 and 500. These records illustrate package differences but do not establish which products or package sizes are currently being distributed.
NDCs distinguish listed drug products and package configurations. A product NDC identifies a specific listed product, while a package-level code identifies a particular packaging presentation. Different labelers or repackagers may use different codes for products containing the same strength.
An application number and an NDC serve different purposes. The FDA application identifies an approved drug product relationship, while the NDC identifies a listed commercial product or package. Neither number alone establishes the pharmacy's present inventory.
The quantity relevant to a patient is the amount authorized by the prescription and dispensed under pharmacy requirements. An original manufacturer package containing 100 or 500 units does not imply that a patient should receive or purchase that amount.
Pharmacy quotations should therefore be compared using the exact dosage form, strength and prescribed quantity. A 500 mg capsule price based on one tablet count should not be compared with a 500 mg tablet price based on a different quantity without clearly identifying the difference.
| Published package example | Dosage form | Labeled strength | Documented package quantities | Evidence limitation |
|---|---|---|---|---|
| DailyMed TEVA-labeled product family | Capsule | 500 mg | 20, 60, 100 and 500 capsules | Published package configurations; not current pharmacy inventory. |
| Historical AMOXIL product labeling | Conventional tablet | 500 mg | 20, 100 and 500 tablets | Historical branded packaging; present marketing requires confirmation. |
Amoxicillin capsules and tablets may have different pharmacy cash prices because they are separate commercial dosage forms. Their respective approved products, suppliers, package configurations, pharmacy acquisition arrangements and payment conditions can differ. The shared 500 mg strength does not guarantee identical pricing.
The cleanest comparison is between a prescribed 500 mg capsule and an appropriately verified 500 mg conventional tablet quotation at the same quantity and pharmacy payment basis. Even then, the difference is a comparison of product prices rather than evidence that the pharmacy may substitute one form for the other.
A drug-price search may default to a capsule even when the prescription specifies a tablet, or vice versa. The selected dosage form should therefore be checked before relying on a published amount. Tablet quantity, manufacturer and pharmacy location may also influence the result.
Insurance and discount programs can classify or process different dosage forms separately. A preferred generic capsule price should not automatically be treated as the insured cost of an amoxicillin tablet. The insurer or pharmacy must confirm the actual product and plan rules.
This page does not publish retailer dollar amounts because they change and would require dated, comparable product-specific offers. The amoxicillin pricing guide owns the broader cash-price discussion. This section addresses the variables unique to the capsule-versus-tablet comparison.
A lower price for one form should not encourage a patient to request a different formulation without professional review. Appropriate prescribing and dispensing take precedence over a price difference.
| Price comparison field | What must be verified | Common mistake |
|---|---|---|
| Active ingredient | Plain amoxicillin | Using an amoxicillin/clavulanate combination price. |
| Strength | 500 mg for a direct overlapping-strength comparison | Comparing 500 mg capsules with 875 mg tablets. |
| Dosage form | Capsule or conventional tablet | Assuming all 500 mg listings refer to the same form. |
| Quantity | Same prescribed unit count | Comparing different quantities or stock-bottle sizes. |
| Product identity | Actual manufacturer or labeler and relevant product record | Treating a generic search result as a particular brand. |
| Payment method | Consistent cash, discount or insurance terms | Mixing a coupon estimate with an insurance copay. |
| Pharmacy and date | Same location and comparable quotation date | Treating historical or regional prices as universal. |
Capsules and tablets are distinct dosage forms in FDA product labeling, even when each contains 500 mg of amoxicillin. A matching active ingredient and nominal strength are relevant facts, but they do not by themselves authorize an automatic dispensing substitution.
An actual substitution decision depends on the prescription, the applicable FDA product relationships and state pharmacy rules. Different approvals or dosage-form classifications may require additional review or prescriber authorization. Patients should not assume that all 500 mg amoxicillin capsules and tablets are interchangeable under every dispensing circumstance.
A prescriber may specify a dosage form for a practical or clinical reason. If a pharmacy cannot supply that form, the pharmacist can determine the appropriate next step and communicate with the prescriber when needed. The patient should not independently change the dosage form or modify the medication to replicate another product.
Crushing a tablet, splitting it or opening a capsule should not be treated as a general workaround for a formulation mismatch. Product-specific labeling and professional instructions govern appropriate handling. A tablet's score line, when present, is also not a universal authorization to change prescribed dosing.
The same caution applies to changing to chewable tablets or oral suspension. Those are distinct dosage forms and may require different preparation or administration instructions.
Amoxicillin is a prescription-only antibiotic. Pharmacy product availability, a discount offer or a preference for capsule versus tablet does not remove the need for lawful dispensing and an appropriate clinical prescription.
Patients reviewing a dispensed amoxicillin product can confirm the drug name, strength, dosage form, prescribed quantity and pharmacy labeling. For the capsule-versus-tablet comparison, the essential distinction is whether the dispensed item is the form authorized by the prescription.
A product's appearance can vary by approved manufacturer or labeler. Color, size and imprint are useful identification details but should be checked against the actual labeled medicine. A different appearance is not automatic evidence of an error, and a familiar appearance is not proof that the product is correct.
The pharmacy can identify the relevant manufacturer, labeler and NDC where appropriate. FDA Orange Book and DailyMed records provide additional regulatory and labeling context. They do not replace the pharmacist's verification of the actual product dispensed.
Plain amoxicillin must also be distinguished from amoxicillin/clavulanate. Augmentin and its generics contain the additional active ingredient clavulanate potassium. A prescription for plain amoxicillin does not authorize dispensing that two-ingredient combination simply because it contains amoxicillin.
Serious hypersensitivity reactions are an important safety consideration for amoxicillin and other beta-lactam antibacterial medicines. A reported allergy requires professional evaluation before use. Antibiotics should also be prescribed only when indicated for a susceptible bacterial infection rather than for viral illnesses such as influenza or the common cold.
The penicillin allergy guide covers hypersensitivity considerations, and the generic amoxicillin guide provides broader product context. This comparison does not offer individualized treatment or dosage-form selection advice.
Both contain amoxicillin as the active ingredient, but they are different oral dosage forms. Capsules contain the formulation within a capsule shell, while conventional tablets are compressed solid products that may have a film coating. Inactive ingredients, appearance, FDA records and packaging may differ.
Yes. U.S. FDA labeling identifies 500 mg as a conventional strength for both amoxicillin capsules and film-coated tablets. The two presentations have separate dosage-form identities and should be verified against the actual prescription.
They contain the same active ingredient and labeled amount of amoxicillin, but they are not identical pharmaceutical presentations. Their inactive ingredients, physical forms, package identifiers and approved product records may differ.
Yes. FDA-labeled conventional amoxicillin capsules include 250 mg and 500 mg strengths. Availability of a particular manufacturer or package requires pharmacy confirmation.
Yes. Conventional film-coated amoxicillin tablets are identified in FDA labeling at 500 mg and 875 mg strengths. These are plain amoxicillin products without clavulanate.
Both identify 500 mg of amoxicillin. The dosage-form name does not by itself establish a stronger clinical effect or superior efficacy. The actual approved product and prescription must be considered.
Yes. Capsules may contain shell materials and capsule-specific excipients, while tablets may contain different binders, disintegrants and coatings. The exact inactive ingredients depend on the individual manufacturer's or labeler's product.
Some FDA-labeled amoxicillin capsules use gelatin shells. This should not be assumed for every product without checking its actual inactive-ingredient list. Patients with ingredient-specific concerns should consult the pharmacist.
Do not assume a capsule can be opened or its contents mixed with food or liquid. Appropriate handling depends on the product's labeling and professional instructions. Ask the pharmacist or prescriber before altering the dosage form.
Tablet alteration should not be assumed safe or appropriate solely because the medicine contains amoxicillin. The pharmacist or prescriber should review the specific product and available options.
A matching active ingredient and strength do not automatically authorize a dosage-form change. The pharmacist must follow the prescription, applicable product requirements and pharmacy laws, including obtaining prescriber clarification where required.
No universal price relationship can be established without comparable current quotations. Dosage form, manufacturer, quantity, pharmacy, payment method and location can all affect the amount charged.
Yes. DailyMed includes product records with different capsule and tablet package quantities. Original manufacturer or repackager bottle sizes should not be confused with the quantity prescribed and dispensed to a patient.
Different listed capsule and tablet products have their own NDC identifiers and package configurations. The code helps identify a labeled drug product or package but does not independently establish FDA approval or current inventory.
No. Plain amoxicillin tablets contain only amoxicillin, whereas Augmentin contains amoxicillin and clavulanate potassium. They are distinct prescription products and should not be substituted based on their shared ingredient.
The main comparison concerns conventional capsules and film-coated tablets, particularly their shared 500 mg strength. Chewable tablets are a separate dosage form and should be evaluated using their own approved product labeling.
Check the dispensing label, dosage form, manufacturer or labeler and product imprint. DailyMed provides product-specific descriptions, but markings vary among approved products. A pharmacist should verify any uncertain identification.
No. Amoxicillin is a prescription-only antibacterial medicine in the United States. Both capsule and tablet products require a valid prescription and lawful pharmacy dispensing.